NYC Project to Convert Former Pfizer Headquarters Lands $135 Million Loan
The effort to convert Pfizer Inc.’s former New York headquarters into residences secured financing to help developers forge ...
Crain's New York2h
Project to convert former Pfizer HQ into housing lands $135M loan
David Werner Real Estate Investments and Metro Loft are planning to turn the 33-story tower and neighboring building into ...
BioSpace1d
Pfizer Gets Breather From Starboard’s Ongoing Assault
Starboard last year took a $1 billion stake in Pfizer, looking to turn the pharma around after alleged severe shortcomings by ...
Pfizer Dodges Challenge to Its Board in Fight With Starboard
Pfizer Inc. got a reprieve — at least for now — in its battle with activist investor Starboard Value LP, according to people ...
FiercePharma2d
Pfizer shells out nearly $60M to resolve Nurtec kickback claims inherited in Biohaven buyout
Over the years, the U.S. Department of Justice (DOJ) has taken a host of drugmakers to task over alleged kickback payments ...
Pfizer Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...
Pfizer Q4 Earnings Preview: 5 Critical Business Issues To Consider
Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.
FiercePharma2d
Pfizer avoids board nominations from Starboard as proxy fight rolls on: Bloomberg
Following a tough opening salvo from Starboard Value last fall, Pfizer is getting a chance to catch its breath in the ...
Zacks.com on MSN20h
Pfizer (PFE) Stock Drops Despite Market Gains: Important Facts to Note
Pfizer (PFE) closed the latest trading day at $26.75, indicating a -0.41% change from the previous session's end. The stock trailed the S&P 500, which registered a daily gain of 0.92%. At the same ...